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hospitalized because of managing acute illness and/or having an
operation (hereafter, maintenance HD inpatients). Besides, 20
patients still had fluid in extravascular space such as edema and/or
pleural effusion. All of them underwent HD three times a week.
In most patients, high-flux membranes with a surface area of
1.4 to 2.2 m2, were used according to clinical conditions. The ul-
trapure dialysate flow was fixed at 500 mL/min. The blood flow
rate was between 220 and 280 mL/min and the length of each
HD or HDF session was between 3.5 and 5 hours.
DW was basically assessed by intradialytic blood pressure,
symptoms related to hypotension, physical examination such as
edema detection and cardiothoracic ratio (CTR). Antihypertensive
drugs were already reduced or removed if possible, especially in
outpatients and maintenance HD inpatients.
Blood pressure was measured i) at the beginning ii) at least
once an hour during the dialysis session, iii) and just after the
dialysis session by oscillometric method. Intradialytic hypotension
was defined as systolic blood pressure decline20 mmHg or
minimum systolic blood pressure110 mmHg, because we had
only 7 patients who had a minimum systolic blood pressure100
mmHgat both dialysis sessions before and after echocardiography
in outpatients (13).
Demographic and clinical characteristics were collected when
IVCdexp was measured. Blood samples for biochemical data were
obtained from arteriovenous shunt just before starting the first
dialysis session of the week. Serum calcium concentration was
adjusted for serum albumin according to the equation : corrected
Ca=measured Ca+(4.0 - serum albumin in g/dL) (14).
IVCdexpmeasurementsbyechocardiography inoutpatients
IVCdexp was measured by echocardiography on non-dialysis
days in outpatients (IVCdexp of non-HD). The method was de-
scribed elsewhere (15). Briefly, IVCdexp was measured in the
subcostal view with the patient in the supine position at 1.0 to 2.0 cm
from the junction with the right atrium, using the long-axis view.
For accuracy, this measurement was made perpendicular to the
IVC long axis. Intradialytic blood pressure was recorded during the
dialysis sessions before and after echocardiography.
IVCdexpmeasurements in inpatients
IVCdexp was measured just before and after the dialysis session
around the time of hospital discharge (IVCdexp of pre-HD and post-
HD). Intradialytic blood pressure was recorded on the day IVCdexp
was measured.
Statistical analysis
All values are expressed as meanSD. Statistical analysis was
performed using SPSS for Windows version 13.0 (SPSS, Inc.,
Chicago, IL, USA). Baseline characteristics between outpatients
and inpatients were compared using student’s t - test or Welch’s t -
test, if data were normally distributed. Non-normal data were
analyzed byMan-Whitney’s U test. F-test was used for comparing
the factors of total deviation. Prevalence data were analyzed by
means of chi -square or Fisher’s exact probability test. Correlation
was analyzed by Peason’s correlation or Spearman’s rank correla-
tion. Significance was defined by P less than 0.05.
RESULTS
Demographic and clinical characteristics
Basic characteristics of enrolled patients were shown in Tables 1
and 2. Compared with inpatients, a higher percentage of outpatients
took antihyperuricemic drugs and fewer took angiotensin II recep-
tor blockers and warfarin. HD duration was longer in outpatients.
Weight gain was larger, the levels of hemoglobin, albumin, blood
urea nitrogen, creatinine, sodium, and potassium were higher and
the ferritin level was lower in outpatients, suggesting outpatients
had better nutritional status and less inflammation.
Among inpatients, 15 were hospitalized to initiate HD. The
others usually underwent HD elsewhere and were temporally
hospitalized because of receiving surgery or invasive treatment.
Significantly more initiation HD inpatients showed hypertension.
They had lower levels of hemoglobin, creatinine and corrected
calcium and higher levels of intact PTH and IVCdexp than mainte-
nance HD inpatients, suggesting they were still on the way to
finding an optimal dialysis prescription (Table 3). Besides, 20
inpatients still had fluid in extravascular space. The inpatients with
fluid were older. Weight gain was larger, albumin level was lower
and ferritin level was higher, indicating they had worse nutritional
and inflammatory status than those without fluid (Table 4).
Diameter of inferior vena cava in outpatients and inpatients
undergoingHD
Figure 1 shows non-HD IVCdexp in outpatients and pre-HD
IVCdexp in inpatients. The IVCdexp values were not significantly
different between outpatients and inpatients (meanSD, 10.6
2.6 mm and 11.53.9 mm, respectively), even if around half of the
inpatients still had hypertension or fluid in extravascular space and
IVCdexp was measured just before starting dialysis in inpatients,
while measured in non-dialysis days in outpatients. The IVCdexp
values were also not different between outpatients and maintenance
HD inpatients. Initiation HD inpatients had wider IVCdexp than
outpatients or maintenance HD inpatients. A higher percentage of
initiation HD patients manifested hypertension (Table 3), suggest-
ing they had not reached optimal DW. Of note, not only 13.1% of
outpatients, but also 28.6% of inpatients who had worse nutritional
Table 1. Primary disease, comorbidity and drug profile of the patients
enrolled.
















DM (%) 38 (35.5%) 12 (34.3%)
HT (%) 55 (51.4%) 24 (68.6%)
Drug
ARB (%)** 17 (15.9%) 12 (34.3%)
ACE−I (%) 0 (0.0%) 2 (5.7%)
Ca antagonist (%) 40 (37.4%) 17 (48.6%)
β−blocker (%) 14 (13.1%) 5 (14.3%)
α−blocker (%) 1 (0.9%) 0 (0.0%)
Vasopressor (%) 1 (0.9%) 2 (5.7%)
Anti−DM (%) 25 (23.4%) 10 (28.6%)
Statin (%) 24 (22.4%) 12 (34.3%)
Anti−UA (%)* 60 (56.1%) 4 (11.4%)
Anti−Plt (%) 57 (53.3%) 12 (34.3%)
Warfarin (%)* 4 (3.7%) 8 (22.9%)
CGN : chronic glomerulonephritis. DM : diabetes mellitus. PCK : poly-
cystic kidney disease. HT : hypertension. ARB : angiotensin II receptor
blocker.
ACE−I : angiotensin converting enzyme inhibitor. Ca antagonist : calcium
antagonist. Anti−UA : antihyperuricemic drug. Anti−Plt : antiplatelet
drug. * : p <0.01. ** : p <0.05
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status than outpatients (Table 2) showed8 mm of non-HD or
pre-HD IVCdexp, which was reported as standard IVCdexp of post-
HD by Ando et al. (7 -9).
Relationship of DW markers with echocardiography findings, clinical
characteristics and minimum systolic blood pressure in outpatients
The markers of DW such as IVCdexp, CTR (1), left ventricular
end-diastolic diameter (LVDd) (16), left atrial diameter (LAD) (17)
were analyzed to investigate the best marker of DW in outpatients.
First, IVCdexp, LVDd and LAD were related to body surface
area, so that the markers were influenced by body size. Next,
IVCdexp was related to LVDd, suggesting IVCdexp measured
volume status. CTR was related to not only LVDd and LAD but
also IVST and PWT. Therefore, CTR reflected on both volume
status and cardiac hypertrophy. LAD was also related to IVST and
PWT. Considering intradialytic systolic blood pressure, LVDd had
the strongest relationship with minimum blood pressure among
the DWmarkers (Table 5).
The values of DW markers in outpatients with or without intradialytic
hypotension
We stratified patients who experienced intradialytic hypoten-
sion during both dialysis sessions before and after echocardiogra-
phy. Only LVDd was significantly different between the groups
with minimum systolic blood pressure110 mmHg and110
mmHg (Table 6).
Diameter of inferior vena cava in inpatients undergoing HD with or
without fluid inextravascularspace
Inpatients were divided into those with fluid in extravascular
space such as edema and/or pleural effusion and those without
fluid. IVCdexp of pre-HD and post-HD in inpatients with fluid
was larger than those in inpatients without fluid, but not signifi-
cantly (pre-HD : 12.34.1 mm and 10.53.4 mm, respectively.
post-HD : 10.34.6 mm and 8.52.9 mm, respectively.). Among
inpatients with fluid, initiation HD patients had wider IVCdexp of
pre-HD than maintenance HD inpatients significantly. Thirty
percent of inpatients with fluid had8 mm of pre-HD IVCdexp,
even if we had to remove the fluid in extravascular space (Figure 2).
DISCUSSION
In this study, we investigated the utility and limitation of IVCdexp.
IVCdexp was related to volume status, but not related to intradia-
lytic minimum blood pressure or predictive for intradialytic hy-
potension. IVCdexp was not significantly different between stable
Table 2. Demographic and clinical characteristics of the patients
enrolled.
Outpatients Inpatients
Patients (n) 107 35
Age (years) 66.3 11.1 63.6 10.6
Female (%) 39 (36.4%) 16 (45.7%)
Body surface area (m2) 1.59 0.18 1.54 0.15
Hemodialysis duration (year)* 10.50 8.16 5.31 10.25
Weight gain (%DW)* 4.2 1.3, 4.1 1.4 3.2 1.5
White blood cell (103/μl) 6.08 1.85 6.48 2.93
Hemoglobin (g/dL)* 11.1 1.2 9.7 1.4
Platelet (104/μl)** 18.1 5.4 21.8 10.3
AST (U/L) 15.3 6.0 19.4 10.4
ALT (U/L) 12.1 5.4 12.9 11.9
LDH (U/L)* 194 44 254 68
Total protein (g/dL) 6.18 0.48 5.92 0.74
Albumin (g/dL)* 3.45 0.33 2.95 0.57
Blood urea nitrogen (mg/dL)* 59.4 13.8 46.5 19.7
Creatinine (mg/dL)* 10.7 2.7 7.0 2.2
Uric acid (mg/dL) 6.17 1.26 5.99 1.91
Sodium (mEq/L)** 140.4 2.8 139.3 3.1
Potassium (mEq/L)* 4.80 0.77 4.17 0.63
Cloride (mEq/L)** 102.6 3.7 104.1 3.9
Corrected calcium (mg/dL) 9.26 0.62 9.39 0.82
Phosphate (mg/dL) 5.14 1.04 4.82 1.50
Iron (μg/dL) 60.6 29.0 58.2 31.3
UIBC (μg/dL)* 201.4 48.7 174.9 57.7
Ferritin (ng/mL)* 77.7 78.7 253.6 433.0
Intact PTH (pg/mL) 134.4 97.0 168.8 169.7
DW : dry weight. UIBC : unsaturated iron binding capacity. PTH : para-
thyroid hormone. * : p <0.01. ** : p <0.05. The values of weight gain in
outpatients were those at the dialysis session before and after echocar-
diography, respectively.
Table 3. Characteristics of inpatients undergoing the initiation of HD or
maintenance HD.
Initiation HD Maintenance HD
Patients (n) 15 20
DM as a primary disease (%) 2 (13.3%) 7 (35.0%)
Comorbidity DM (%), HT (%)** 4 (26.7%), 13 (86.7%) 8(40.0%), 11(55.0%)
Age (years) 65.1 8.7 62.5 12.0
Female (%) 9 (60.0%) 7 (35.0%)
Body surface area (m2) 1.53 0.17 1.55 0.13
Hemodialysis duration (year)* 0.04 0.02 9.26 12.24
Weight gain (%DW) 2.7 1.6 3.7 1.3
SBP at the beginning (mmHg) 144.4 17.7 135.2 33.7
Minimum intradialytic SBP (mmHg) 121.9 14.7 113.8 16.2
IVCdexp. pre−*,post−HD** (mm) 13.53.6, 11.14.2 10.13.4, 8.33.5
White blood cell (103/μl) 6.14 1.64 6.74 3.63
Hemoglobin (g/dL)* 9.1 1.2 10.2 1.3
Platelet (104/μl) 19.1 6.2 23.9 12.3
AST (U/L) 20.5 8.8 18.6 11.6
ALT (U/L) 14.3 8.3 11.8 14.1
LDH (U/L) 273 65 240 68
Total protein (g/dL) 5.77 0.54 6.04 0.85
Albumin (g/dL) 2.95 0.44 2.95 0.67
Blood urea nitrogen (mg/dL) 50.5 21.6 43.4 18.1
Creatinine (mg/dL)** 6.1 1.6 7.7 2.3
Uric acid (mg/dL) 6.07 1.91 5.94 1.96
Sodium (mEq/L) 139.5 3.0 139.1 3.3
Potassium (mEq/L) 4.09 0.63 4.22 0.63
Cloride (mEq/L) 105.5 3.8 103.1 3.7
Corrected calcium (mg/dL)* 8.98 0.36 9.70 0.93
Phosphate (mg/dL) 4.52 0.88 5.05 1.84
Iron (μg/dL) 58.9 22.0 57.6 38.0
UIBC (μg/dL) 183.9 61.0 167.5 55.5
Ferritin (ng/mL) 225.4 185.4 275.8 561.9
Intact PTH (pg/mL)* 278.5 190.3 72.0 53.4
DM : diabetes mellitus. HT : hypertension. DW : dry weight. SBP :
systolic blood pressure. IVCdexp : inferior vena cava diameter on
expiration. HD : hemodialysis. UIBC : unsaturated iron binding capacity.
PTH : parathyroid hormone.
* : p <0.01. ** : p <0.05.
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outpatients and relatively unstable inpatients, suggesting IVCdexp
was not a definitive volume status marker. IVCdexp was not signifi-
cantly different between inpatients without fluid in extravascular
space and those with fluid, indicating IVCdexp was not a practical
DW marker.
IVCdexp was reported as an easily measurable DW marker (2).
The IVCdexp value itself can be believed as a definitive marker to
avoid intradialytic hypotension or symptoms of hypovolemia. In
our study, IVCdexp was larger in initiation HD inpatients who did
not reach optimal DW than that in maintenance HD patients
(Figure 1). IVCdexp decreased after HD treatment (Figure 2).
IVCdexp was related to LVDd in outpatients (Table 5). Therefore,
IVCdexp could reflect on volume status. However, IVCdexp had a
poor relationship with minimum intradialytic blood pressure or
intradialytic hypotension (Table 6). IVCdexp did not have a correla-
tion with interdialytic weight gain as a percentage of estimated dry
weight in our outpatients (data not shown). Non-HD IVCdexp in
outpatients ranged from 5.4 to 16.9 mm, and pre-HD IVCdexp in
inpatients ranged from 6 to 21 mm. There is a large overlap among
outpatients with optimal DW and inpatients including50% patients
without practical DW (Figure 1, Table 3, 4). In addition, basically,
inpatients have different nutritional status and hemodynamics with
low serum albumin and hemoglobin concentration because of the
change of diet and activity compared with outpatients (17). In this
study, inpatients had lower serum albumin and hemoglobin con-
centration than outpatients (Table 2). It is likely that IVCdexp value
itself could not be a definitive DW marker and only showed exces-
sive hypovolemia or hypervolemia (18).
IVCdexp was body size dependent (Table 5). It is compatible
with the previous report which showed a strong correlation of
IVCdexp with height and weight in the normal Indian population
(19). In edematous patients, IVCdexp was not significantly related
to edema severity (Figure 2) (20). Therefore, we have to recognize
the reference value of IVCdexp was dependent on clinical charac-
teristics such as age, body size and comorbidities (10).
LVDd can be a better marker for assessing DW than IVCdexp.
LVDd was related to minimum intradialytic blood pressure (Table
5). LVDd was significantly larger in outpatients without intradialytic
hypotension than LVDd in those with intradialytic hypotension
(Table 6). We guess that the LVDd values are affected by fewer
factors including volume status than the IVCdexp values. There-
fore, in order to avoid intradialytic hypotension, it might be better to
measure LVDd than IVCdexp.
We do not deny the utility of IVCd, because we did not measure
Table 4. Characteristics of inpatients without or with fluid in extravas-
cular space.
Without fluid With fluid
Patients (n) 15 20
DM as a primary disease (%) 4 (26.7%) 5 (25.0%)
Comorbidity DM (%), HT (%) 6(40.0%), 11(73.3%) 6(30.0%), 13(65.0%)
Age (years)* 58.6 6.6 67.3 11.7
Female (%) 8 (53.3%) 8 (40.0%)
Body surface area (m2) 1.56 0.16 1.52 0.15
Hemodialysis duration (year) 8.96 14.41 2.57 4.09
Weight gain (%DW)** 2.6 1.5 3.7 1.4
SBP at the beginning (mmHg) 144.1 21.0 135.4 32.3
Minimum intradialytic SBP (mmHg) 119.3 13.2 115.7 17.8
IVCdexp. pre−,post−HD (mm) 10.53.4, 8.52.9 12.34.1, 10.34.6
White blood cell (103/μl) 5.84 1.64 6.96 3.57
Hemoglobin (g/dL) 9.9 1.3 9.7 1.4
Platelet (104/μl) 23.4 9.5 20.6 10.9
GOT (U/L) 19.5 12.4 19.3 9.0
GPT (U/L) 13.2 15.7 12.7 8.5
LDH (U/L) 236 42 268 80
Total protein (g/dL) 6.10 0.61 5.79 0.81
Albumin (g/dL)* 3.29 0.25 2.70 0.62
Blood urea nitrogen (mg/dL) 44.3 11.0 48.1 24.5
Creatinine (mg/dL) 7.6 2.1 6.6 2.2
Uric acid (mg/dL) 5.89 1.99 6.08 1.89
Sodium (mEq/L) 140.1 2.3 138.7 3.5
Potassium (mEq/L) 4.27 0.54 4.09 0.69
Cloride (mEq/L) 103.9 3.9 104.2 4.1
Corrected calcium (mg/dL) 9.48 0.84 9.33 0.82
Phosphate (mg/dL) 5.19 1.75 4.53 1.24
Iron (μg/dL) 61.1 27.0 55.9 34.7
UIBC (μg/dL)* 208.2 56.0 150.4 46.5
Ferritin (ng/mL)** 116.5 93.8 349.6 544.1
Intact PTH (pg/mL) 209.1 220.9 137.5 113.1
DM : diabetes mellitus. HT : hypertension. DW : dry weight. SBP :
systolic blood pressure. IVCdexp : inferior vena cava diameter on
expiration. HD : hemodialysis. UIBC : unsaturated iron binding capacity.
PTH : parathyroid hormone.
* : p <0.01. ** : p <0.05.
Figure1. Inferior vena cava on expiration in outpatients and inpatients.
The inferior vena cava diameter on expitration (IVCdexp) values were not significantly different between outpatients on non-dialysis days and
inpatients before starting dialysis session. The IVCdexp values were not also different between outpatients and maintenance hemodialysis (HD)
inpatients. Initiation HD inpatients had wider IVCdexp than outpatients or maintenance HD inpatients significantly. Circle : outpatients. Triangle with
circle : initiation HD patients. Triangle : maintenance HD patients.
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inspiratory collapse of IVCd. Collapsing index which is calculated
by the formula : (IVCd on expiration - IVCd on inspiration) /
IVCd on expiration *100, was reported as a usefulDW maker than
IVCd on expiration only (21). ASE recommendation from the
American Society of Echocardiography and the European Associa-
tion of Cardiovascular Imaging for IVCdexp and collapsing index to
estimate right atrial pressure was shown previously (15). IVCdexp
21 mm that collapses50% with a sniff suggests normal right atrial
pressure of 3 mmHg (range, 0 to 5 mmHg), whereas IVCdexp21
mm that collapses50% with a sniff suggests high right atrial
pressure of 15 mmHg (range, 10 to 20 mmHg) (22). The measure-
ment of three-dimensional areas measured from cross-sectional
images of the IVC may also be promising to monitor volume status
(23, 24). However, collapsing index depends on the patient’s effort
and the variation of ultrasound results can happen among different
operators (25-29). Therefore, IVCd is a rough method to estimate
volume status and we should not rely on a single method to
determine DW in patients undergoing HD (30).
A weakness of this study is its relatively small sample size,
especially in inpatients. In addition, the timing of IVCd measurement
was different between outpatients and inpatients.
In summary, in this study, we demonstrated that IVCdexp could
reflect on volume status, but was not a definitive marker for deter-
mining DW. The IVCd values can be suggestive to avoid apparent
hypervolemia/hypovolemia, but we have to consider the patient’s
condition to interpret the IVCd results.
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Table 5. Relationship of dry weight markers with echocardiography findings, clinical characteristics and minimum systolic blood pressure in
outpatients.
IVCde CTR LVDd LAD IVST PWT BSA minipr minipost
IVCde −0.092 0.254 0.184 −0.160 −0.169 0.256 0.203 0.121
CTR −0.092 0.230 0.202 0.205 0.245 −0.067 −0.023 0.047
LVDd 0.254 0.230 0.355 0.130 0.187 0.427 0.345 0.228
LAD 0.184 0.202 0.355 0.308 0.353 0.329 0.277 0.179
IVCde : inferior vena cava diameter on expiration. CTR : cardiothoracic ratio. LVDd : left ventricular end−diastolic diameter. LAD : left atrial
diameter. IVST : interventricular septum thickness. PWT : left ventricular posterior wall thickness. BSA : body surface area. minipr : minimum
intradialytic systolic blood pressure during the dialysis session before echocardiography. minipost : minimum intradialytic systolic blood pressure
during the dialysis session after echocardiography.
upright : Peason’s correlation coefficient.
oblique : Spearman’s rank correlation coefficient.
hatching : correlation coefficient >0.2.
Table 6. The values of dry weight markers in outpatients with or without intradialytic hypotension.
mSBP110 (29) mSBP>110 (78) IDH<20 (55) IDH20 (52) IDH<30 (80) IDH30 (27)
IVCdexp 1.01 0.20 1.08 0.27 1.09 0.24 1.03 0.27 1.08 0.24 1.01 0.28
CTR 49.4 5.0 50.1 5.4 49.8 6.0 50.0 0.44 49.7 5.5 50.3 4.7
LVDd 4.56 0.45 4.76 0.44** 4.73 0.43 4.68 0.47 4.72 0.44 4.65 0.47
LAD 3.79 0.57 3.90 0.50 3.84 0.54 3.90 0.50 3.85 0.54 3.93 0.47
mSBP : minimum intradialytic systolic blood pressure.
IDH<20 : intradialytic hypotension less than 20 mmHg.
IVCdexp : inferior vena cava diameter on expiration. CTR : cardiothoracic ratio. LVDd : left ventricular end−diastolic diameter. LAD : left atrial
diameter. ** : p <0.05.
Figure 2. Inferior vena cava on expiration of pre -HD and post -HD in
inpatients with or without fluid in extravascular space.
(A,B) Inferior vena cava on expiration (IVCdexp) of pre -hemodialysis
(HD) (A) and post -HD (B) in inpatients. IVCdexp of pre -HD and post -
HD in inpatients with fluid was larger than those in inpatients without
fluid, but not significantly. (A) Among inpatients with fluid, initiation HD
patients had wider IVCdexp of pre -HD than maintenance HD inpatients
significantly. Six among twenty inpatients with fluid had8 mm of pre -
HD IVCdexp, even if we had to remove the fluid in extravascular space.
Triangle with circle : initiation HD patients. Triangle : maintenance HD
patients.
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